Find a TenderAwardedContract details notice
Published 19 May 2025, 16:08 BST

Official UK procurement notice

Provision of Armed Forces Compulsory Drug Testing

Official notice

Authority: Ministry of Defence (Central government)

ServicesOpen procedureAbove thresholdSME suitableVCSE suitable
Published estimate£15,000,000≈ £3.0m / year · £18,000,000 inc. VAT
Submissions closed 4 Nov 2025awarded 5 Mar 2026
Awarded to DNA Workplace Ltd2 awards
Contract term 5 yrsends 31 Mar 2031 · up to 31 Mar 2031 with extensions · starts 1 Apr 2026

What is being bought

Published requirement description

The Armed Forces Compulsory Drug Testing Programme is the largest occupational drug-testing programme in Europe and was established in January 1995. It is designed to reduce the incidence of substance misuse in the Armed Forces by detection and deterrence underpinned by education and policy. Currently between 100,000 - 125,000 samples are collected per annum. In addition to testing for drug misuse, there is also the requirement for the contractor to conduct screening for steroids and new psychoactive substances.

The programme involves the analysis of urine samples of service personnel. Samples are collected by Armed Forces collection teams and transported to the laboratory of the Authority's urinalysis contractor.

The programme also requires research and scientific support. These areas are included in this contract, which is structured to provide maximum flexibility to cope with change during its life.

  • The authority expects to re-tender this requirement around 2 Dec 2030, 23:59 GMT.

CPV: Analysers · Drug detection apparatus · Health services · Laboratory services · Urologist services

The lotProcurement structure

single lot · value published
Lot #1AwardedRenewal 5 yrsSMEVCSEPublished value£15,000,000
Contract period: 1 Apr 2026 – 31 Mar 2031 (5 yrs) · up to 31 Mar 2031 with extensionsValue: £15,000,000 exc. VAT · £18,000,000 inc. VAT
Delivery: South EastEligibility: SME eligibleVCSE eligible
Extensions: Extension options published
Pre-qualification & selection criteria (PQQ)2
  • Economic & financial standing

    Turnover

    The Authority will review each Potential Provider Entity’s turnover for the three full financial years prior to the date of the ITT. If the estimated annual contract value for this procurement exceeds fifty per cent. (50%) of a Potential Provider's annual turnover, the Potential Provider will not meet this qualification standard.

    Where the Potential Provider Entity intends to provide all or some of of the required services via a joint-venture company, Consortium Member, or other special purpose vehicle, the Authority will apply the assessment equally to the Potential Provider Entity.

    Accordingly, where the annual contract value turnover exceeds 50% of the value of a Potential Provider Entity turnover (assessed as the cumulation of all parties turnover in either the joint venture, Consortia or special purpose vehicle), the Potential Provider Entity will not meet this qualification standard.

    Liquidity ratios

    A Potential Provider Entity’s current assets are divided by current liabilities to establish if there are sufficient assets to cover all of the Potential Provider Entity’s liabilities as they fall due over the course of one year. The Authority requires a Potential Provider Entity to have:

    a minimum current ratio of 1.0; and

    a minimum acid test ratio of 0.8.

    If these ratios are not met, the Potential Provider Entity will not meet this qualification standard.

    Company Watch

    Company Watch "H-Score" (an overall measure of a business' financial health – for more information, see www.companywatch.net/analytics-insight/h-… ↗). If a Potential Provider Entity does not have a score of 20 or above, the Potential Provider Entity will not meet this qualification standard.

    Where Company Watch “H-Score” is unavailable or for international companies, Net Debt/EBITDA (below) will be used as an alternative.

    Net Debt/EBITDA An entity’s EBITDA is a proxy for the cash flow it generates from its ongoing operations. The Net Debt to EBITDA Ratio measures an entity’s ability to service its debt.

    The Authority requires a Potential Provider Entity to have:

    a maximum of 2.5x

    If this ratio is not met, the Potential Provider Entity will not meet this qualification standard.

  • Technical & professional ability

    Tenderers must be UKAS accredited or demonstrate ability to gain UKAS accredication to the satisfaction of the Authority by the contract start date.

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
  • Tehcnical requirements: Please see attached DEFFORM 47 ITT
  • Social Value: Please see attached DEFFORM 47 ITT
  • Total value of Tender including extensions: Total value of Tender including extensions priced in accodordance with Variation of Price, please see tender documents, VOP can be seen at condition 47.4 of the terms and conditions (SC2)
Conditions of participation2
  • Economic & financial standing

    Turnover

    The Authority will review each Potential Provider Entity’s turnover for the three full financial years prior to the date of the ITT. If the estimated annual contract value for this procurement exceeds fifty per cent. (50%) of a Potential Provider's annual turnover, the Potential Provider will not meet this qualification standard.

    Where the Potential Provider Entity intends to provide all or some of of the required services via a joint-venture company, Consortium Member, or other special purpose vehicle, the Authority will apply the assessment equally to the Potential Provider Entity.

    Accordingly, where the annual contract value turnover exceeds 50% of the value of a Potential Provider Entity turnover (assessed as the cumulation of all parties turnover in either the joint venture, Consortia or special purpose vehicle), the Potential Provider Entity will not meet this qualification standard.

    Liquidity ratios

    A Potential Provider Entity’s current assets are divided by current liabilities to establish if there are sufficient assets to cover all of the Potential Provider Entity’s liabilities as they fall due over the course of one year. The Authority requires a Potential Provider Entity to have:

    a minimum current ratio of 1.0; and

    a minimum acid test ratio of 0.8.

    If these ratios are not met, the Potential Provider Entity will not meet this qualification standard.

    Company Watch

    Company Watch "H-Score" (an overall measure of a business' financial health – for more…

  • Technical & professional ability

    Tenderers must be UKAS accredited or demonstrate ability to gain UKAS accredication to the satisfaction of the Authority by the contract start date.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Services
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Yes · next expected 2 Dec 2030
First published
19 May 2025, 16:08 BST
Last source update
28 Apr 2026, 15:15 BST
Award evaluation window
Submission end – 15 Jan 2026
Authority reference
714890452
FTS notice number
2025/S 000-063967
Latest notice
Contract details notice (UK7)
Classification (CPV)
AnalysersDrug detection apparatusHealth servicesLaboratory servicesUrologist services
Delivery area
UK
Official registry OCID
ocds-h6vhtk-051776 Find a Tender

How it was run

Official notice
Run through: Defence Sourcing Portal · Who buys & how to bid on MOD DSP
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Free · registration requires an NCAGE code — obtain in advance · before you can bid: NCAGE
Submission deadline
4 Nov 2025, 11:00 GMT
Clarification deadline
16 Oct 2025, 18:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

Please submit response on the Defence Sourcing Portal via the following link: contracts.mod.uk/go/2210270901999AC76049 ↗

Timeline

19 May 2025 → 28 Apr 2026 · 11 dates
  1. Planning notice published
    19 May 2025, 16:08 BST
  2. Market engagement
    14 Jul 2025, 23:59 BST

    REQUEST FOR INFORMATION

    REFERENCE: 62081818 – Armed Forces Compulsory Drug Testing Programme (AFCDT)

    CUSTOMER: APSG, D Pers, Ministry of Defence (The Authority)

    INTENDED CONTRACT START DATE: 01 April 2026

    DATE RESPONSE REQUIRED: 14 July 2025

    Dear Potential Provider,

    We would like to notify you of a potential upcoming requirement, and by doing so we are keen to understand where the market stands in terms of our requirement below.

    The UK MOD is conducting market research with the intention of continuing the provision of the AFCDT. AFCDT is designed to reduce the incidence of SM in the Armed Forces (AF) by detection and deterrence underpinned by education and policy. Currently between 100,000 and 125,000 samples are collected per annum. The AF remains committed to the AFCDT, recognising the risk to Operational Effectiveness (OE) and Risk to Life (RtL) resultant from Substance Misuse (SM). All SP (Army, Navy and Air Force) are subject to Service Law are liable for AFCDT from date of attestation. Samples are collected by the AFCDT Teams (military personnel) on a 24/7 basis and transported to the urinalysis contractor’s laboratory, under a separate transport contract.

    The current AFCDT is broken up into two contracts, the Urine Analysis (UA) AFCDT Contract and the AFCDT Assurance Contract (AC). This RFI only covers the AFCDT Urine Analysis Contract requirements.

    Please note the following general conditions:

    • This RFI will help us to refine the requirement and conduct market research.
    • We reserve the right not to proceed with this procurement. Nothing shall constitute a commitment to instigating a formal procurement process.
    • Any and all costs associated with the production of such a response either to an RFI or any resultant competition must be borne by the Supplier. The Authority will not contribute in any way to meeting production costs of any response.
    • No down-selection of Potential Providers will take place as a consequence of any responses or interactions relating to this RFI.
    • We expect that all responses to this RFI will be provided by Potential Providers in good faith to the best of their ability in the light of information available at the time of their response.
    • No information provided by a Potential Provider in response to this RFI will be carried forward, used or acknowledged in any way for the purpose of evaluating the Potential Provider, in any subsequent formal procurement process that may take place.
    • Should a Potential Provider fail to respond to this Supplier Questionnaire, it will not affect any further participation in any possible future procurement for this capability.

    OUR AIMS – WHAT WE WANT TO ACHIEVE

    The Customer is looking for one or more Suppliers to deliver the following aims:

    a. Provision of suitable robust specimen collection kits and regulation compliant transport packaging.

    b. The screening by urinalysis of all samples and the conduct of confirmation analysis where necessary applying recognized accredited methods.

    c. The ability to conduct hair testing on an ad-hoc basis.

    d. Secure delivery of results electronically to the Authority.

    e. Ability to conduct DNA analysis on an ad-hoc basis.

    f. Ability to conduct enhanced analysis i,e workplace steroids, New or Novel Psychoactive Substances (NPS) and other emerging trends, up to 10% of the overall samples, or on request.

    g. Regulation compliant storage of samples.

    h. Destruction of bio-hazard waste.

    i. Training, inspections and liaison: and

    j. Customer support (including toxicology evidence and expert legal witness testimony where necessary).

    WHAT WE ARE LOOKING FOR

    The Customer is looking for Industry feedback on the following areas:

    1. There is an appetite for a singular provider to deliver all requirements detailed in the brief as a capability under a single contract, can this be achieved by your organisation?
    2. How would the potential provider seek to service the contract, which includes the provision of testing kits, clinical waste disposal, IT infrastructure, communications and overall technical support throughout.
    3. Do any potential providers have the current capacity to deliver the capabilities? If a potential provider has a solution or is willing to develop a solution that fulfils the requirement, please provide a summary of the solution.
    4. If the potential provider does not have a current solution that meets the requirement in full, what level of investment would the potential provider envisage as a result, or would the potential provider seek to sub-contract capabilities, and how would this sub-contract capability be managed.
    5. Are there any major pit falls, issues or risks with the requirement?
    6. How would a potential provider bring innovation to the testing process, for example a testing kit that indicates a positive result at the time of testing. Which can then be sent for further analysis.
    7. Where possible, are you able to provide a submission of a rough order of magnitud in regard to how much it may cost to the Authority fulfil this requirement in full, for 5 years.
    8. Where possible, confirm the lead time to establish a robust logistical plan for the delivery of test kits and other potential lead times to have a facility that provides the service up and running.
    9. If not, UKAS accredited, how long would it take for you to achieve this or similar accreditation required by the UK Government to conduct this requirement.
    10. How is your service currently measured by other customers of your services i.e. Key Performance Indicators.
    11. Are you able to provide examples of Key Performance Indicators?
    12. What are the most applicable social value missions and outcomes that be achieved in fulfilment of the requirement?

    (Please see assets.publishing.service.gov.uk/media/67ae1529e270ce… ↗)

    1. Are there any outcomes that provide tenderers the best opportunity to deliver greater benefit to social, economic and the environment missions and outcomes through the performance of the potential contract than other outcomes listed in the above link?

    POTENTIAL PROVIDER QUESTIONS AND CLARIFICATIONS

    • Potential Providers may raise questions or seek clarification regarding any aspect of this RFI document at any time prior to the Clarification Period Closure, as detailed in 'our timeline'. Questions must be submitted through the Defence Sourcing Portal (DSP).
    • To ensure that all Potential Providers have equal access to information regarding this Procurement, responses to questions raised by Potential Providers will be published in a questions and answers document, which will be available through the DSP.
    • Responses to questions will not identify the originator of the question.
    • If a Potential Provider wishes to ask a question or seek clarification without the question and answer being published in this way, then the Potential Provider must notify us and provide its justification for withholding the question and any response. If the Authority does not consider that there is sufficient justification for withholding the question and the corresponding response, the Potential Provider will be invited to decide whether:

    o the question/clarification and the response should in fact be published; or

    o It wishes to withdraw the question/clarification.

    INSTRUCTIONS FOR COMPLETION AND RETURN

    • Answers should be limited to a maximum of one side of A4 per question, using Ariel Font, Size 11.
    • Once completed please save as a PDF file and return to: [email protected]
    • Completed questionnaires should be returned by no later than COP 17:00 14 July 2025. Along with your completed responses you are invited to provide any marketing material/information that would help the MOD understand more about your organization and the market you operate in. Please note that failure to respond to this Supplier Questionnaire will not affect any further participation in any possible future procurement for this capability.

    The full Statement of Requirement is attached to the opportunity listing on the Defence Sourcing Portal, this be accessed by clicking on the following link:

    A DSP account will need to be created to access the link

  3. Next notice expected
    25 Aug 2025, 23:59 BST
  4. Tender notice published376 days ago
    10 Oct 2025, 08:22 BST
  5. Clarification questions by369 days ago
    16 Oct 2025, 18:00 BST
  6. Submission deadline351 days ago
    4 Nov 2025, 11:00 GMT
  7. Award decision expected by278 days ago
    15 Jan 2026, 23:59 GMT
  8. Assessment summaries sent230 days ago
    5 Mar 2026
  9. Standstill ends218 days ago
    16 Mar 2026, 23:59 GMT
  10. Contract starts203 days ago
    1 Apr 2026, 00:00 BST
  11. Latest notice published176 days ago
    28 Apr 2026, 15:15 BST

Notice history

14 events · 9 releases on Find a Tender · since 19 May 2025
  1. Pipeline notice published
    19 May 2025, 16:08 BST
    UK1
  2. Preliminary market engagement notice published
    12 Jun 2025, 14:07 BST
    UK2
  3. Preliminary market engagement notice published
    13 Jun 2025, 11:54 BST
    UK2
  4. Tender notice published
    10 Oct 2025, 08:22 BST
    UK4
  5. Status changed to active
    10 Oct 2025, 08:22 BST
  6. Procurement method changed
    10 Oct 2025, 08:22 BST
  7. Deadline published: 4 Nov 2025, 11:00 GMT
    10 Oct 2025, 08:22 BST
  8. Contract award notice published
    5 Mar 2026, 10:47 GMT
    UK6
  9. Status changed to complete
    5 Mar 2026, 10:47 GMT
  10. Contract award notice published
    5 Mar 2026, 11:36 GMT
    UK6
  11. Contract signature expected
    17 Mar 2026, 23:59 GMT
    scheduled
  12. Contract award notice published
    18 Mar 2026, 15:30 GMT
    UK6
  13. Contract details notice published
    28 Apr 2026, 14:40 BST
    UK7
  14. Contract details notice published
    28 Apr 2026, 15:15 BST
    UK7
Published amendments (1)

Update to Defence Sourcing Portal link.

Routine re-releases (9)
  • 2026-03: 2 releases · 5 Mar 2026, 5 Mar 2026
  • 2025-10: 1 release · 10 Oct 2025
  • 2025-06: 2 releases · 12 Jun 2025, 13 Jun 2025
  • 2025-05: 1 release · 19 May 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 2
Awarded value £15,000,0001 contract exc. VAT · 1 repeated publication of the same award counted once
Bids received 4
Named bidders 4published on the award notice
Contracts signed 1latest 10 Apr 2026
Awarded toValueDateStatus
DNA Workplace LtdSMEProvision of Armed Forces Compulsory Drug Testing Programme1 Apr 2026 – 31 Mar 2031Amended: Update to Associated people/organisations of the contract.£15,000,000same award published again · counted once5 Mar 2026standstill to 16 Mar 2026Standstill
DNA Workplace LtdSME£15,000,000 †—Awarded

Contracts

  • Provision of the Armed Forces Compulsory Drug Testing Programme · DNA Workplace LtdSME

    Signed
    10 Apr 2026
    Value
    £15,000,000
    Period
    10 Apr 2026 – 9 Apr 2031
    Status
    active
    • Change amendment to title of notice
    3 agreed KPIs: KPI-1 · KPI-2 · KPI-3
    • KPI-1, Service Availability – Core Hours between 08:30- 17:00hrs Monday to Thursday and 08:30-16:30hrs on Friday excluding Bank Holidays, Privilege days and stand down periods, All output (hours) provided by the Service Provider in support of the requirement. Deliver the service during the stated hours and provide an accurate response to questions relating to the deliverables, during operating hours/agreed time frames. Services requested outside these hours will be arranged by the Authority and agreed by the Service Provider 48hrs in advance.
    • KPI-2, Timely & accurate Test results – The ability to deliver accurate test results in support of the Armed Forces Substance Misuse policy and procedures. Test results are delivered within an agreed timeframe within the SOR and contain accurate details on what substance was used and quantity. (Within 5 working days of receipt of the sample at the Service Provider’s premises)
    • KPI-3, Logistical support– The supply of specimen collection kits, supporting paperwork which includes consignment forms and drug testing forms. Detailed within the Statement of Requirement. The delivery of specimen collection kits and supporting documentation in advance of UK and overseas testing taking place. The kits and supporting documentation should be delivered 4 weeks in advance.

Bid statistics published by the authority

BidsSMEVCSEValid bid range
4final-stage tenders00—

Who bid

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

Ministry of Defence

Contracting authorityPublic authority - central government GB-PPON: PHVX-4316-ZVGZ Monxton Road, Andover, South East, SP11 8HTContact name, email

Bidders & participating suppliers

4 commercial parties on the notice · 1 awarded
  • Abbott Toxicology LtdBidder / tendererGB-PPON: PRDT-1748-HMPH 21 Blacklands way, Abingdon, South East, OX14 1DY
  • DNA Workplace LtdAwarded supplierGB-PPON: PMZQ-2349-ZMHT Frome Business Park, Frome, South West, BA11 4FNContact email
  • Eurofins Forensic ServicesBidder / tendererGB-PPON: PMCR-6828-NRWG Queens Road, Teddington, London, TW11 0LY
  • Randox LaboratoriesBidder / tendererGB-PPON: PDGP-3243-ZXQW 55 Diamon Road, Antrim, Northern Ireland, BT29 4QY

Official documents & specifications (9)

Official links; attachments are not copied

Notices published for this procedure